McDonnell Boehnen Hulbert & Berghoff LLP is proud to be an official sponsor of the 2018 Southeast BIO (“SEBIO”) Investor & Partnering Forum set for November 13-14, 2018 in Atlanta, GA. The Forum works to advance biopharmaceutical, medical technology, agricultural biotechnology and other life science companies, from ideas at the research stage to early-stage and more mature start-up companies.
The Southeast BIO (SEBIO) Investor & Partnering Forum provides an unparalleled opportunity to meet key decision makers in the regional and national life science and medical technology communities. Since its inception, the SEBIO Investor & Partnering Forum has built a loyal following, attracting thought leaders and investors from across the country. More than 300 biotech and medtech investors, corporate executives, university representatives, entrepreneurs and service providers will attend the event this year. To date, the more than 220 later stage and 180 early stage companies that participated in previous SEBIO Investor & Partnering Forums have raised more than $2.5 billion in public and private funding. These numbers speak to the quality of the presenting companies.
SEBIO is a regional non-profit organization that fosters the growth of the life sciences industry in the Southeastern United States through efforts that promote entrepreneurship and bring together the key players active in the development of the industry. SEBIO’s geographic footprint presently includes Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Virginia.
View complete details at http://www.southeastbio.org/.